Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zehao Zheng

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Medicine|September 24, 2025
Causal associations of renal function and sudden sensorineural hearing loss: Evidence from a two-sample multivariable Mendelian randomization study with case-control validationZehao Zheng, Yuqi Zhou, Jiali Wei, et al.
Computers in Biology and Medicine|July 6, 2025
Leveraging machine learning and single-cell RNA sequencing strategies to develop a risk prognosis scoring based on liquid-liquid phase separation feature genes in pediatric hepatoblastomaD Q Cai, DianKui Cai, Zhen Zhao, et al.
Ultrasonics Sonochemistry|August 28, 2024
Effect of ultrasound-assisted pH-shifting treatment on the physicochemical properties of melon seed proteinGuojun Fu, Man Zhao, Xinmiao Wang, et al.
Clinical Immunology (Orlando, Fla.)|March 17, 2023
Peripheral Th and NK cells are associated with response to lenvatinib plus PD-1 inhibitor in unresectable hepatocellular carcinomaYiping Zou, Zhihong Chen, Zhenrong Chen, et al.
Frontiers in Immunology|January 27, 2025
Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinomaZehao Zheng, Renguo Guan, Rongce Zhao, et al.
Liver Cancer|April 17, 2026
Survival Outcomes, Recurrence Patterns, and Its Corresponding Therapeutic Management after Conversion Therapy Followed by Curative Resection for Hepatocellular Carcinoma: A Real-World StudyRui Xiao, Zhenyun Yang, Zehao Zheng, et al.
International Journal of Surgery (London, England)|March 29, 2024
Patients with hepatocellular carcinoma extrahepatic metastases can benefit from hepatic arterial infusion chemotherapy combined with lenvatinib plus programmed death-1 inhibitorsRenguo Guan, Nan Zhang, Min Deng, et al.
European Journal of Medical Research|February 10, 2026
DLGAP5 regulates malignancy and lenvatinib sensitivity of hepatocellular carcinoma through AKT/mTOR/NF-κB pathwayBenyi He, Min Deng, Renguo Guan, et al.
BMC Medicine|June 30, 2026
Adjuvant systemic therapy versus active surveillance after resection following conversion therapy for hepatocellular carcinoma: a propensity score matched studyBenyi He, Zehao Zheng, Junyu Gan, et al.
Disease Markers|March 22, 2021
Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal AdenocarcinomaZuyi Ma, Zixuan Zhou, Hongkai Zhuang, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Medicine|September 24, 2025
Causal associations of renal function and sudden sensorineural hearing loss: Evidence from a two-sample multivariable Mendelian randomization study with case-control validationZehao Zheng, Yuqi Zhou, Jiali Wei, et al.
Computers in Biology and Medicine|July 6, 2025
Leveraging machine learning and single-cell RNA sequencing strategies to develop a risk prognosis scoring based on liquid-liquid phase separation feature genes in pediatric hepatoblastomaD Q Cai, DianKui Cai, Zhen Zhao, et al.
Ultrasonics Sonochemistry|August 28, 2024
Effect of ultrasound-assisted pH-shifting treatment on the physicochemical properties of melon seed proteinGuojun Fu, Man Zhao, Xinmiao Wang, et al.
Clinical Immunology (Orlando, Fla.)|March 17, 2023
Peripheral Th and NK cells are associated with response to lenvatinib plus PD-1 inhibitor in unresectable hepatocellular carcinomaYiping Zou, Zhihong Chen, Zhenrong Chen, et al.
Frontiers in Immunology|January 27, 2025
Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinomaZehao Zheng, Renguo Guan, Rongce Zhao, et al.
Liver Cancer|April 17, 2026
Survival Outcomes, Recurrence Patterns, and Its Corresponding Therapeutic Management after Conversion Therapy Followed by Curative Resection for Hepatocellular Carcinoma: A Real-World StudyRui Xiao, Zhenyun Yang, Zehao Zheng, et al.
International Journal of Surgery (London, England)|March 29, 2024
Patients with hepatocellular carcinoma extrahepatic metastases can benefit from hepatic arterial infusion chemotherapy combined with lenvatinib plus programmed death-1 inhibitorsRenguo Guan, Nan Zhang, Min Deng, et al.
European Journal of Medical Research|February 10, 2026
DLGAP5 regulates malignancy and lenvatinib sensitivity of hepatocellular carcinoma through AKT/mTOR/NF-κB pathwayBenyi He, Min Deng, Renguo Guan, et al.
BMC Medicine|June 30, 2026
Adjuvant systemic therapy versus active surveillance after resection following conversion therapy for hepatocellular carcinoma: a propensity score matched studyBenyi He, Zehao Zheng, Junyu Gan, et al.
Disease Markers|March 22, 2021
Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal AdenocarcinomaZuyi Ma, Zixuan Zhou, Hongkai Zhuang, et al.
Pageof 4